发明名称 |
Alkyne substituted quinazoline compound and methods of use |
摘要 |
The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (e.g., cancer). |
申请公布号 |
AU2017200984(A1) |
申请公布日期 |
2017.03.02 |
申请号 |
AU20170200984 |
申请日期 |
2017.02.14 |
申请人 |
NewGen Therapeutics, Inc. |
发明人 |
SHEN, Wang;ZHANG, Aimin;MAUNG, Jack;ZHENG, Xiaoling |
分类号 |
A61K31/4706 |
主分类号 |
A61K31/4706 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|